Table.
Genetic testing availability at level IV NICUs
| Test type | Available without restriction (N, %) | Available with restrictions (N, %) | Results available within 2 weeks (N, %) |
|---|---|---|---|
| Karyotype | 30, 94% | 2, 6% | 27, 84% |
| Chromosomal microarray | 25, 78% | 7, 22% | 18, 56% |
| Single gene or gene panel | 18, 56% | 13, 41% | 6, 32% |
| Exome sequencing | 6, 19% | 26, 81% | 16, 50% |
| Genome sequencinga | 5, 16% | 24, 75% | 18, 56% |
| Mitochondrial sequencinga | 10, 32% | 18, 56% | 3, 9% |
a
Mitochondrial sequencing was reported to be unavailable at one institution, and GS and mitochondrial sequencing were each reported to be only available for research purposes at one institution. Two responses were missing for GS and mitochondrial sequencing.